The person depicted is a model used for illustrative purposes only.
REMICADE® can reduce the signs and symptoms and induce and maintain remission in pediatric patients aged 6-17 with moderately to severely active Crohn’s disease who haven’t responded well to other therapies.
If your child is currently taking medication and still experiencing the symptoms of Crohn’s
Talk with your doctor to decide if REMICADE® may be right for your child.
REMICADE® isn’t right for everyone, and individual results may vary. Talk with your doctor to decide if REMICADE® may be right for your child.